Painter R B
J Environ Pathol Toxicol. 1978 Sep-Oct;2(1):65-78.
Inhibition of HeLa cell DNA synthesis by DNA-damaging agents as a test for mutagenic carcinogens has been investigated further. Several mutagens and/or carcinogenic agents not previously assayed for DNA synthesis inhibition were tested and found to be positive. The effect of two DNA-damaging agents administered simultaneously was investigated: With ultraviolet light (UV) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) the effects were partly additive, whereas with MNNG and ICR-170 they were not. When UV was administered simultaneously with hydroxyurea (HU), a non-DNA-damaging inhibitor of DNA synthesis, the effects of the DNA-damaging agent were still evident after HU was removed and the HU-induced DNA synthesis inhibition reversed. Therefore, although the test probably cannot determine whethter there are one or more DNA-damaging agents in an unknown mixture, the presence of a powerful DNA synthesis inhibitor that is not a DNA-damaging agent will not mask the effects of a DNA-damaging agent in the same sample. Despite the fact that ICR-170 induces little DNA repair in xeroderma pigmentosum (XP) cells, which are deficient in excision repair, the inhibition of DNA synthesis induced by this agent was less in XP cells than in HeLa cells. The inhibition of DNA synthesis by MNNG was also less in XP than in HeLa cells. Therefore, contrary to expectations, the use of a repair-deficient cell did not increase the sensitivity of the test. Various in vitro mammalian cell tests are compared. Assays for unscheduled DNA synthesis are much less sensitive to intercalating agents, such as adriamycin, and to X-rays than are assays for inhibition of DNA synthesis but takes longer and requires more specialized skills than does measurement of DNA synthesis inhibition. Finally, the in vitro HeLa DNA synthesis inhibition test is compared with the in vivo DNA synthesis inhibition test with mouse testes.
对DNA损伤剂抑制HeLa细胞DNA合成作为诱变致癌物检测方法进行了进一步研究。测试了几种以前未检测过对DNA合成抑制作用的诱变剂和/或致癌剂,发现结果呈阳性。研究了同时给予两种DNA损伤剂的效果:紫外线(UV)和N-甲基-N'-硝基-N-亚硝基胍(MNNG)的效果部分具有加和性,而MNNG和ICR-170则不然。当UV与羟基脲(HU)(一种非DNA损伤的DNA合成抑制剂)同时给予时,在去除HU且HU诱导的DNA合成抑制作用逆转后,DNA损伤剂的作用仍然明显。因此,尽管该检测可能无法确定未知混合物中是否存在一种或多种DNA损伤剂,但非DNA损伤剂的强力DNA合成抑制剂的存在不会掩盖同一样品中DNA损伤剂的作用。尽管ICR-170在缺乏切除修复的着色性干皮病(XP)细胞中几乎不诱导DNA修复,但该试剂诱导的DNA合成抑制在XP细胞中比在HeLa细胞中要小。MNNG对DNA合成的抑制在XP细胞中也比在HeLa细胞中要小。因此,与预期相反,使用修复缺陷细胞并没有提高检测的灵敏度。比较了各种体外哺乳动物细胞检测方法。与DNA合成抑制检测相比,非定标DNA合成检测对嵌入剂(如阿霉素)和X射线的敏感性要低得多,但比DNA合成抑制测量耗时更长且需要更专业的技术。最后,将体外HeLa细胞DNA合成抑制检测与小鼠睾丸体内DNA合成抑制检测进行了比较。